Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Diamond

Concepts (315)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
16
2024
200
6.300
 Why?
Breast Neoplasms
26
2026
2257
4.390
 Why?
Immunoconjugates
7
2023
125
2.440
 Why?
Antineoplastic Agents
23
2023
2169
2.430
 Why?
Antineoplastic Combined Chemotherapy Protocols
20
2025
1793
2.350
 Why?
Pyrimidines
9
2021
512
2.240
 Why?
Protein Kinase Inhibitors
11
2025
919
1.780
 Why?
Piperazines
5
2023
373
1.620
 Why?
Paclitaxel
6
2022
237
1.530
 Why?
Camptothecin
9
2023
123
1.510
 Why?
Neoplasms
14
2022
2747
1.440
 Why?
Pyrazoles
6
2021
482
1.290
 Why?
Ovarian Neoplasms
5
2025
581
1.250
 Why?
Quinoxalines
2
2020
68
1.250
 Why?
Azepines
3
2020
97
1.190
 Why?
Antibodies, Monoclonal, Humanized
10
2024
913
1.160
 Why?
Histone Deacetylase Inhibitors
4
2024
211
1.150
 Why?
Cyclin-Dependent Kinase 4
2
2018
46
1.050
 Why?
Cyclin-Dependent Kinase 6
2
2018
41
1.040
 Why?
Carcinoma, Lobular
3
2026
53
0.870
 Why?
Neutropenia
4
2022
157
0.840
 Why?
Benzoxazoles
2
2021
20
0.830
 Why?
Xenograft Model Antitumor Assays
12
2026
907
0.750
 Why?
Gene Expression Regulation, Neoplastic
5
2020
1435
0.730
 Why?
Breast Neoplasms, Male
2
2018
29
0.710
 Why?
beta Catenin
2
2020
258
0.700
 Why?
Female
54
2026
75943
0.660
 Why?
Chemotherapy, Adjuvant
4
2023
381
0.660
 Why?
Receptors, Estrogen
3
2021
412
0.660
 Why?
Maximum Tolerated Dose
9
2022
206
0.660
 Why?
Cancer Care Facilities
1
2020
43
0.650
 Why?
eIF-2 Kinase
1
2019
31
0.620
 Why?
Lymphocytes, Tumor-Infiltrating
2
2020
210
0.610
 Why?
Pyridines
5
2025
557
0.590
 Why?
Tumor Microenvironment
4
2024
703
0.590
 Why?
Anthracyclines
3
2023
43
0.580
 Why?
Humans
67
2026
141754
0.580
 Why?
Taxoids
3
2023
102
0.570
 Why?
Aged
26
2025
24746
0.550
 Why?
Aurora Kinase A
4
2020
55
0.540
 Why?
Carcinoma, Ductal, Breast
1
2018
81
0.540
 Why?
Wnt Signaling Pathway
1
2019
202
0.540
 Why?
Trastuzumab
4
2023
97
0.530
 Why?
Drug Resistance, Neoplasm
4
2020
833
0.530
 Why?
Aromatase Inhibitors
3
2025
58
0.510
 Why?
Pyrazines
2
2018
88
0.510
 Why?
Colonic Neoplasms
1
2018
246
0.490
 Why?
Myocardial Infarction
1
2023
1069
0.490
 Why?
Tumor Suppressor Protein p53
4
2024
529
0.470
 Why?
Angiopoietin-1
1
2015
11
0.460
 Why?
Angiopoietin-2
1
2015
15
0.460
 Why?
Neoplasm Recurrence, Local
5
2025
1078
0.460
 Why?
Neoadjuvant Therapy
1
2018
424
0.460
 Why?
Nuclear Proteins
2
2023
719
0.460
 Why?
Cell Line, Tumor
10
2026
3495
0.440
 Why?
Medicare
4
2023
808
0.420
 Why?
Middle Aged
27
2025
34647
0.410
 Why?
Bridged-Ring Compounds
2
2023
27
0.410
 Why?
Uterine Cervical Neoplasms
1
2017
288
0.400
 Why?
Colorectal Neoplasms
5
2022
805
0.390
 Why?
Adult
28
2025
39391
0.390
 Why?
Dose-Response Relationship, Drug
6
2022
2064
0.380
 Why?
Quinolines
4
2025
172
0.380
 Why?
Tumor Suppressor Proteins
1
2015
326
0.380
 Why?
Proto-Oncogene Proteins c-met
1
2013
73
0.380
 Why?
Antibodies, Monoclonal
4
2024
1474
0.380
 Why?
Cell Proliferation
8
2020
2506
0.380
 Why?
Treatment Outcome
13
2025
11181
0.380
 Why?
Recombinant Fusion Proteins
1
2015
674
0.370
 Why?
Antineoplastic Agents, Immunological
3
2019
195
0.370
 Why?
Point Mutation
1
2013
237
0.370
 Why?
Radiosurgery
3
2025
393
0.370
 Why?
Triazoles
1
2013
162
0.360
 Why?
Angiogenesis Inhibitors
3
2018
230
0.350
 Why?
Mice, Nude
6
2020
691
0.340
 Why?
Aged, 80 and over
10
2025
7923
0.340
 Why?
Clinical Trials, Phase I as Topic
2
2020
53
0.330
 Why?
Carcinoma, Renal Cell
1
2013
225
0.330
 Why?
Heart Failure
1
2023
2093
0.330
 Why?
Mitochondria
1
2017
979
0.320
 Why?
Histones
3
2023
639
0.320
 Why?
Genes, BRCA2
1
2009
30
0.320
 Why?
Neoplasm Metastasis
4
2020
676
0.310
 Why?
Genes, BRCA1
1
2009
41
0.310
 Why?
Adaptor Proteins, Signal Transducing
2
2026
439
0.310
 Why?
Biomarkers, Tumor
2
2014
1258
0.300
 Why?
Molecular Targeted Therapy
3
2019
420
0.300
 Why?
BRCA2 Protein
1
2009
62
0.300
 Why?
Pregnancy Complications, Neoplastic
1
2009
57
0.300
 Why?
Thrombophilia
1
2009
90
0.290
 Why?
Neoplasm Staging
5
2021
1401
0.290
 Why?
Apoptosis
7
2024
2576
0.290
 Why?
Kidney Neoplasms
1
2013
408
0.290
 Why?
Lung Neoplasms
2
2024
2567
0.290
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2026
134
0.280
 Why?
Adenine
2
2021
331
0.280
 Why?
Receptors, Progesterone
2
2021
337
0.270
 Why?
DNA-Binding Proteins
1
2015
1485
0.270
 Why?
Mice
10
2026
18109
0.260
 Why?
Models, Biological
1
2014
1828
0.250
 Why?
Cell Cycle Proteins
3
2026
632
0.240
 Why?
Selective Estrogen Receptor Modulators
1
2025
32
0.230
 Why?
Doxorubicin
3
2024
360
0.230
 Why?
Cardiorespiratory Fitness
1
2025
69
0.220
 Why?
Cyclophosphamide
2
2018
257
0.210
 Why?
DNA Repair
1
2026
239
0.210
 Why?
Trans-Activators
1
2026
394
0.200
 Why?
Disease Models, Animal
3
2021
4421
0.200
 Why?
Animals
12
2026
37749
0.200
 Why?
United States
5
2023
15310
0.190
 Why?
Liver Neoplasms
1
2009
741
0.190
 Why?
Brain Neoplasms
3
2025
1305
0.190
 Why?
Biopsy
2
2018
1083
0.190
 Why?
Cyclin-Dependent Kinase 9
1
2022
18
0.190
 Why?
Histone Deacetylase 1
1
2022
20
0.190
 Why?
Aurora Kinases
2
2012
28
0.180
 Why?
G2 Phase Cell Cycle Checkpoints
3
2022
44
0.180
 Why?
Administration, Oral
3
2022
803
0.180
 Why?
Topoisomerase I Inhibitors
2
2022
16
0.180
 Why?
Fluorouracil
1
2022
206
0.180
 Why?
Disease Progression
4
2019
2800
0.180
 Why?
Acetylation
1
2022
245
0.170
 Why?
Androstadienes
1
2021
78
0.170
 Why?
Arrhythmias, Cardiac
1
2023
337
0.170
 Why?
Biliary Tract Neoplasms
1
2021
31
0.170
 Why?
Diarrhea
2
2019
184
0.170
 Why?
Carboplatin
1
2021
146
0.170
 Why?
Heterografts
1
2021
134
0.170
 Why?
Drug Administration Schedule
3
2017
771
0.170
 Why?
Hospitals, University
1
2021
175
0.170
 Why?
Necrosis
2
2019
249
0.160
 Why?
Cancer Survivors
1
2025
302
0.160
 Why?
Histone Deacetylases
1
2022
210
0.160
 Why?
Fatigue
2
2022
339
0.160
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.160
 Why?
Immunotherapy
2
2023
646
0.160
 Why?
Clinical Trials as Topic
3
2016
1057
0.160
 Why?
Immune System
1
2021
183
0.160
 Why?
Benzodiazepines
1
2021
162
0.150
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
40
0.150
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
132
0.150
 Why?
Male
14
2021
70179
0.150
 Why?
Kaplan-Meier Estimate
1
2021
910
0.150
 Why?
Tumor Cells, Cultured
1
2020
962
0.150
 Why?
Albumins
1
2019
116
0.140
 Why?
Maintenance Chemotherapy
1
2018
38
0.140
 Why?
Aquaporin 4
1
2019
102
0.140
 Why?
Nausea
1
2018
111
0.140
 Why?
Vascular Endothelial Growth Factor A
2
2018
554
0.140
 Why?
Aminopyridines
1
2018
109
0.140
 Why?
Mice, Inbred BALB C
1
2020
1275
0.140
 Why?
Drug Therapy, Combination
1
2020
1041
0.140
 Why?
Antibodies, Bispecific
1
2018
60
0.140
 Why?
Breast
1
2018
158
0.130
 Why?
Purines
1
2018
182
0.130
 Why?
Radiotherapy, Adjuvant
1
2018
219
0.130
 Why?
Topotecan
1
2017
13
0.130
 Why?
Benzimidazoles
1
2018
186
0.130
 Why?
Mastectomy
1
2018
153
0.130
 Why?
Isoflavones
1
2017
26
0.130
 Why?
Calcium-Binding Proteins
1
2018
217
0.130
 Why?
Imidazoles
1
2018
255
0.130
 Why?
Survival Analysis
1
2020
1320
0.130
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
19
0.130
 Why?
Carbolines
1
2017
35
0.130
 Why?
Programmed Cell Death 1 Receptor
1
2019
261
0.130
 Why?
Inhibitory Concentration 50
2
2016
91
0.130
 Why?
Hypertension
2
2018
1254
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
103
0.120
 Why?
Cell Survival
1
2019
1134
0.120
 Why?
Retrospective Studies
4
2025
16374
0.120
 Why?
Insulin-Like Growth Factor I
1
2018
325
0.120
 Why?
GPI-Linked Proteins
1
2016
78
0.120
 Why?
Neoplasms, Second Primary
1
2016
110
0.120
 Why?
Antibodies, Neoplasm
1
2015
33
0.120
 Why?
Tumor Protein p73
1
2015
18
0.110
 Why?
Nanoparticles
1
2021
484
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2024
1127
0.110
 Why?
Phosphorylation
1
2019
1774
0.110
 Why?
Hodgkin Disease
1
2016
157
0.110
 Why?
Risk Reduction Behavior
1
2016
227
0.110
 Why?
Oxazoles
2
2025
46
0.110
 Why?
Maytansine
1
2014
18
0.110
 Why?
Demography
1
2015
296
0.110
 Why?
Brain Edema
1
2014
64
0.110
 Why?
Protein Kinases
1
2015
308
0.100
 Why?
Drug Interactions
1
2015
406
0.100
 Why?
Exercise
1
2025
2112
0.100
 Why?
Survival Rate
2
2019
1972
0.100
 Why?
Threonine
1
2013
47
0.100
 Why?
Sulfones
1
2014
127
0.100
 Why?
Tumor Stem Cell Assay
1
2012
34
0.100
 Why?
Quinazolines
2
2025
260
0.100
 Why?
Randomized Controlled Trials as Topic
1
2019
1634
0.100
 Why?
Drug Evaluation, Preclinical
1
2013
196
0.100
 Why?
Glycine
1
2014
185
0.100
 Why?
Diabetes Mellitus, Type 2
2
2025
2537
0.100
 Why?
Drug Design
1
2013
168
0.100
 Why?
Time Factors
2
2020
6966
0.090
 Why?
Methionine
1
2013
159
0.090
 Why?
Heterozygote
1
2013
308
0.090
 Why?
Disease-Free Survival
1
2014
718
0.090
 Why?
In Situ Hybridization, Fluorescence
1
2013
311
0.090
 Why?
Treatment Failure
1
2013
354
0.090
 Why?
Analgesics, Opioid
1
2021
1123
0.090
 Why?
Neovascularization, Pathologic
1
2013
296
0.090
 Why?
Cell Transformation, Neoplastic
1
2013
334
0.090
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
231
0.090
 Why?
Carcinoma in Situ
1
2011
43
0.090
 Why?
Cluster Analysis
1
2012
521
0.090
 Why?
Risk Assessment
1
2020
3508
0.090
 Why?
Computational Biology
1
2015
664
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
85
0.080
 Why?
Risk Factors
2
2025
10482
0.080
 Why?
Cellular Senescence
1
2012
206
0.080
 Why?
Colorado
1
2020
4629
0.080
 Why?
Sequence Analysis, DNA
1
2013
825
0.080
 Why?
Mutation
2
2012
4015
0.080
 Why?
Tumor Burden
1
2010
312
0.080
 Why?
Keratinocytes
1
2010
252
0.080
 Why?
Pregnancy Trimester, Second
1
2009
83
0.080
 Why?
Mastectomy, Segmental
1
2009
101
0.070
 Why?
Pregnancy Trimester, First
1
2009
139
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
194
0.070
 Why?
Lymph Node Excision
1
2009
169
0.070
 Why?
Risk
1
2009
907
0.060
 Why?
Cell Adhesion Molecules
2
2019
180
0.060
 Why?
Infusions, Intravenous
2
2019
417
0.060
 Why?
Prognosis
2
2018
4080
0.060
 Why?
Phthalazines
1
2026
62
0.060
 Why?
Gene Expression Profiling
1
2012
1771
0.060
 Why?
Antigens, Neoplasm
2
2019
322
0.060
 Why?
CD8-Positive T-Lymphocytes
2
2023
918
0.060
 Why?
Accelerometry
1
2025
109
0.050
 Why?
Cell Cycle
2
2018
600
0.050
 Why?
Combined Modality Therapy
2
2019
1249
0.050
 Why?
Follow-Up Studies
2
2025
5212
0.050
 Why?
Mesylates
1
2022
6
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
70
0.050
 Why?
Signal Transduction
2
2014
5169
0.050
 Why?
Oxygen Consumption
1
2025
715
0.050
 Why?
Clinical Protocols
1
2023
273
0.050
 Why?
Ligands
1
2024
667
0.050
 Why?
RNA, Small Interfering
1
2024
627
0.040
 Why?
Chimerism
1
2021
33
0.040
 Why?
Lymphocyte Subsets
1
2021
88
0.040
 Why?
Liver
1
2009
1820
0.040
 Why?
Lymphoid Tissue
1
2021
81
0.040
 Why?
Mice, SCID
1
2021
367
0.040
 Why?
Hormones
1
2020
140
0.040
 Why?
SEER Program
1
2021
221
0.040
 Why?
Mice, Inbred NOD
1
2021
600
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
 Why?
Tissue Distribution
1
2018
330
0.030
 Why?
Infant, Newborn
1
2009
6289
0.030
 Why?
Anemia
1
2019
177
0.030
 Why?
Blood Glucose
2
2025
2278
0.030
 Why?
Insulin Resistance
1
2025
1225
0.030
 Why?
Pregnancy
1
2009
7092
0.030
 Why?
Cetuximab
1
2016
105
0.030
 Why?
Retreatment
1
2016
73
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
122
0.030
 Why?
Neoplasm Transplantation
1
2016
250
0.030
 Why?
Drug Screening Assays, Antitumor
1
2016
193
0.030
 Why?
Carotid Artery Diseases
1
1996
62
0.030
 Why?
Platinum
1
2016
51
0.030
 Why?
Arterial Occlusive Diseases
1
1996
89
0.030
 Why?
History, Ancient
1
2015
53
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2016
263
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
671
0.030
 Why?
C-Peptide
1
1996
167
0.030
 Why?
Transcription Factors
1
2023
1712
0.030
 Why?
Femoral Artery
1
1996
184
0.030
 Why?
Carotid Arteries
1
1996
201
0.030
 Why?
Databases, Genetic
1
2015
243
0.030
 Why?
Diabetic Angiopathies
1
1996
251
0.030
 Why?
DNA Damage
1
2017
429
0.030
 Why?
Biomarkers
2
2016
4190
0.030
 Why?
Mice, Knockout
1
2021
3071
0.030
 Why?
Cross-Sectional Studies
1
2025
5697
0.030
 Why?
Quality of Life
1
2025
3014
0.020
 Why?
Opioid-Related Disorders
1
2021
564
0.020
 Why?
Phenotype
1
2021
3177
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
258
0.020
 Why?
Drug Combinations
1
2013
368
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
467
0.020
 Why?
Immunohistochemistry
1
2016
1739
0.020
 Why?
Lipids
1
1996
690
0.020
 Why?
Biopsy, Needle
1
2011
187
0.020
 Why?
Proto-Oncogene Proteins
1
2014
624
0.020
 Why?
HT29 Cells
1
2010
41
0.020
 Why?
Cohort Studies
1
2021
5815
0.020
 Why?
Protein-Tyrosine Kinases
1
2013
431
0.020
 Why?
Enzyme Inhibitors
1
2014
855
0.020
 Why?
Transcription, Genetic
1
2017
1487
0.020
 Why?
ErbB Receptors
1
2013
610
0.020
 Why?
Ki-67 Antigen
1
2010
111
0.020
 Why?
Capillary Permeability
1
2010
149
0.020
 Why?
Patient Selection
1
2013
688
0.020
 Why?
Patient Satisfaction
1
2013
697
0.020
 Why?
Positron-Emission Tomography
1
2010
310
0.020
 Why?
Membrane Proteins
1
2015
1158
0.020
 Why?
Algorithms
1
2015
1768
0.020
 Why?
Magnetic Resonance Imaging
1
2019
3737
0.020
 Why?
Tomography, X-Ray Computed
1
2016
2765
0.010
 Why?
Insulin
1
1996
2491
0.010
 Why?
Adolescent
1
2024
22130
0.010
 Why?
Brain
1
2014
2868
0.010
 Why?
Young Adult
1
2014
13749
0.010
 Why?
Tunica Media
1
1996
36
0.010
 Why?
Cholesterol, HDL
1
1996
196
0.010
 Why?
Fasting
1
1996
284
0.010
 Why?
Cholesterol
1
1996
405
0.010
 Why?
Regression Analysis
1
1996
1023
0.010
 Why?
Ultrasonography
1
1996
761
0.010
 Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (315) concept(s)
_
Co-Authors Expand Description
See all (73) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)